Organization and Description of Business - Additional Information (Detail) - Checkpoint Therapeutics, Inc [Member] $ in Millions |
9 Months Ended |
|---|---|
|
Sep. 30, 2015
USD ($)
| |
| Organization And Nature Of Business [Line Items] | |
| Debt Issuance Cost | $ 12.6 |
| Allocated Share-based Compensation Expense | $ 1.5 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees). No definition available.
|
| X | ||||||||||
- Details
|